August 11, 2006 – Over the years, Genitope has endured its shares of disappointments as it has struggled to produce a therapeutic cancer vaccine. But a recent low-profile release sparked enthusiasm among the residual group of true believers in the company. We look at the prospects for MyVax and use the drug as a springboard to discuss the possibilities behind the entire field of vaccines as a therapy for cancer...
